- The FDA has cleared a Parametric Sound (PAMT +2.8%) hearing aid that leverages the company's HyperSound audio tech.
- Parametric argues HyperSound's use of ultrasonic frequencies and a proprietary emitter allows it to direct sound towards an individual listener who isn't wearing headphones, as well as produce 3D effects.
- The company has also claimed HyperSound can enable hearing aids superior to traditional solutions that "provide too much amplification in the lower frequencies and too little in the needed higher frequencies."
Parametric obtains FDA clearance for HyperSound hearing aid
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs